Clearline Capital’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.81M | Buy |
3,618,163
+400,269
| +12% | +$1.08M | 0.37% | 43 |
|
|
2025
Q1 | $7.24M | Hold |
3,217,894
| – | – | 0.44% | 45 |
|
|
2024
Q4 | $11.3M | Sell |
3,217,894
-26,440
| -0.8% | -$92.5K | 1.49% | 20 |
|
|
2024
Q3 | $13.3M | Sell |
3,244,334
-82,384
| -2% | -$339K | 0.57% | 31 |
|
|
2024
Q2 | $12M | Hold |
3,326,718
| – | – | 0.33% | 28 |
|
|
2024
Q1 | $11M | Hold |
3,326,718
| – | – | 0.54% | 30 |
|
|
2023
Q4 | $7.68M | Buy |
3,326,718
+223,995
| +7% | +$517K | 0.47% | 40 |
|
|
2023
Q3 | $4M | Buy |
3,102,723
+1,157,683
| +60% | +$1.49M | 0.34% | 70 |
|
|
2023
Q2 | $2.57M | Sell |
1,945,040
-107,669
| -5% | -$142K | 0.15% | 66 |
|
|
2023
Q1 | $1.45M | Hold |
2,052,709
| – | – | 0.22% | 69 |
|
|
2022
Q4 | $1.54M | Sell |
2,052,709
-1,904,426
| -48% | -$1.43M | 0.28% | 74 |
|
|
2022
Q3 | $3.41M | Buy |
3,957,135
+898,539
| +29% | +$774K | 0.41% | 57 |
|
|
2022
Q2 | $3.43M | Buy |
3,058,596
+1,756,813
| +135% | +$1.97M | 0.44% | 54 |
|
|
2022
Q1 | $1.46M | Buy |
1,301,783
+615,491
| +90% | +$689K | 0.17% | 84 |
|
|
2021
Q4 | $1.1M | Buy |
+686,292
| New | +$1.1M | 0.12% | 89 |
|